|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-4-14
|
|
pubmed:abstractText |
The efficacy of rituximab given alone or in combination with chemotherapy on naive or relapsed indolent lymphoma is good. This study was to investigate the efficacy and safety of rituximab-containing regimens for patients with indolent B-cell lymphoma in China.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1000-467X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
490-4
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16613687-Adult,
pubmed-meshheading:16613687-Aged,
pubmed-meshheading:16613687-Antibodies, Monoclonal,
pubmed-meshheading:16613687-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:16613687-Antineoplastic Agents,
pubmed-meshheading:16613687-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16613687-Cyclophosphamide,
pubmed-meshheading:16613687-Disease-Free Survival,
pubmed-meshheading:16613687-Doxorubicin,
pubmed-meshheading:16613687-Exanthema,
pubmed-meshheading:16613687-Female,
pubmed-meshheading:16613687-Follow-Up Studies,
pubmed-meshheading:16613687-Humans,
pubmed-meshheading:16613687-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:16613687-Leukopenia,
pubmed-meshheading:16613687-Lymphoma, B-Cell, Marginal Zone,
pubmed-meshheading:16613687-Lymphoma, Follicular,
pubmed-meshheading:16613687-Male,
pubmed-meshheading:16613687-Middle Aged,
pubmed-meshheading:16613687-Prednisone,
pubmed-meshheading:16613687-Remission Induction,
pubmed-meshheading:16613687-Seizures, Febrile,
pubmed-meshheading:16613687-Thrombocytopenia,
pubmed-meshheading:16613687-Vincristine
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
[Efficacy of rituximab-containing regimens on indolent B-cell lymphoma--a report of 34 cases].
|
|
pubmed:affiliation |
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, P. R. China. xiazhj@medmail.com.cn
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
